Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab (R-CHOP) Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell (DLBCL) NHL: Southwest Oncology Group Study S0515

被引：0
|
作者：
Stopeck, Alison T. [1 ]
Unger, Joseph M. [2 ]
Rimsza, Lisa M. [3 ]
Farnsworth, Brent [3 ]
LeBlanc, Michael [2 ]
Iannone, Maria [1 ]
Fisher, Richard I. [4 ]
Miller, Thomas P. [1 ]
机构：
[1] Arizona Canc Ctr, Tucson, AZ USA
[2] SW Oncol Grp, Seattle, WA USA
[3] Univ Arizona, Tucson, AZ USA
[4] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [21] OUTCOMES IN PATIENTS WITH PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA AFTER RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (R-CHOP) CHEMOTHERAPY
    Suh, C.
    Sohn, B. S.
    Yoon, D. H.
    Kim, S.
    Lee, D. H.
    Kim, S. W.
    Huh, J. R.
    Lee, J. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 650 - 650
  • [22] Outcomes in patients with primary gastric diffuse large B-cell lymphoma after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy
    Sohn, B.
    Yoon, D.
    Kim, S.
    Lee, D.
    Kim, S.
    Huh, J.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Phase I Trial of Carfilzomib plus R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Hill, Brian T.
    Dean, Robert M.
    Jagadeesh, Deepa
    Garcia, Alex V. Mejia
    Pohlman, Brad
    Winter, Allison M.
    Krauspe, Ethan
    Collier, Patrick
    D'Andrea, Christopher
    Morrison, Ashley
    Lehmann, Sarah
    Tomlinson, Benjamin K.
    Cooper, Brenda
    de Lima, Marcos
    Ondrejka, Sarah L.
    Hsi, Eric D.
    Caimi, Paolo
    BLOOD, 2018, 132
  • [24] Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL)
    Younes, Anas
    Flinn, Ian
    Berdeja, Jesus G.
    Friedberg, Jonathan W.
    Alberti, Sara
    Thieblemont, Catherine
    Morschhauser, Franck
    Hellemans, Peter
    Hall, Brett
    Smit, Johan
    Skee, Donna
    de Vries, Ronald
    Todorovic, Marija
    Khan, Imran
    Fourneau, Nele
    Oki, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma
    Micallef, I. N.
    Maurer, M. J.
    Nikcevich, D. A.
    Cannon, M.
    Moore, D. F., Jr.
    Kurtin, P.
    Witzig, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Pharmacokinetic and pharmacodynamic evaluation of a biosimilar rituximab in newly diagnosed diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, prednisolone)
    Viswabandya, Auto
    Prashanthi, P. V.
    Raju, C. Nirmala
    Rajsekhar, Reena
    Mathews, Vikram
    Madki, Shivkumar
    Abhayankar, Dhiraj
    Kethireddypally, Rukmini
    George, Biju
    Chandy, Mammen
    Reddy, Cartikeya
    Srivastava, Alok
    BLOOD, 2007, 110 (11) : 194B - 194B
  • [27] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
    Sehn, Laurie
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
  • [28] Limited-Stage Diffuse Large B-cell Lymphoma in Head and Neck Treated With CHOP or Rituximab-CHOP (R-CHOP) Plus Radiation Therapy
    Ohga, S.
    Nakamura, K.
    Shioyama, Y.
    Sasaki, T.
    Nonoshita, T.
    Yoshitake, T.
    Asai, K.
    Hirata, H.
    Honda, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S618 - S618
  • [29] Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
    Manos, Kate
    Chong, Geoffrey
    Keane, Colm
    Lee, Sze-Ting
    Smith, Charmaine
    Churilov, Leonid
    McKendrick, Joseph
    Renwick, William
    Blombery, Piers
    Burgess, Melinda
    Nelson, Niles Elizabeth
    Fancourt, Tineke
    Hawking, Joanne
    Lin, Wendi
    Scott, Andrew M.
    Barraclough, Allison
    Wight, Joel
    Grigg, Andrew
    Fong, Chun Yew
    Hawkes, Eliza A.
    LEUKEMIA, 2023, 37 (05) : 1092 - 1102
  • [30] Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
    Kate Manos
    Geoffrey Chong
    Colm Keane
    Sze-Ting Lee
    Charmaine Smith
    Leonid Churilov
    Joseph McKendrick
    William Renwick
    Piers Blombery
    Melinda Burgess
    Niles Elizabeth Nelson
    Tineke Fancourt
    Joanne Hawking
    Wendi Lin
    Andrew M. Scott
    Allison Barraclough
    Joel Wight
    Andrew Grigg
    Chun Yew Fong
    Eliza A. Hawkes
    Leukemia, 2023, 37 : 1092 - 1102
12345